Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Operating Expenses: 2009-2011

Historic Operating Expenses for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $33.7 million.

  • Lexicon Pharmaceuticals' Operating Expenses rose 42.26% to $33.7 million in Q4 2011 from the same period last year, while for Dec 2011 it was $115.9 million, marking a year-over-year increase of 15.22%. This contributed to the annual value of $115.9 million for FY2011, which is 15.22% up from last year.
  • Lexicon Pharmaceuticals' Operating Expenses amounted to $33.7 million in Q4 2011, which was up 29.33% from $26.0 million recorded in Q3 2011.
  • Lexicon Pharmaceuticals' 5-year Operating Expenses high stood at $33.7 million for Q4 2011, and its period low was $23.7 million during Q4 2010.
  • Its 3-year average for Operating Expenses is $26.7 million, with a median of $26.0 million in 2011.
  • As far as peak fluctuations go, Lexicon Pharmaceuticals' Operating Expenses fell by 8.12% in 2010, and later skyrocketed by 42.26% in 2011.
  • Lexicon Pharmaceuticals' Operating Expenses (Quarterly) stood at $25.8 million in 2009, then dropped by 8.12% to $23.7 million in 2010, then skyrocketed by 42.26% to $33.7 million in 2011.
  • Its Operating Expenses was $33.7 million in Q4 2011, compared to $26.0 million in Q3 2011 and $26.5 million in Q2 2011.